We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Tissue Bank for Pulmonary Diseases

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2011 by Boston Children’s Hospital.
Recruitment status was:  Recruiting
ClinicalTrials.gov Identifier:
First Posted: October 19, 2007
Last Update Posted: May 13, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Harvard University
Information provided by:
Boston Children’s Hospital
The aim of this research study is to collect and store the specimens that are left over after patients undergo tests ordered by their physicians. These specimens will be used at a later time by researchers in the Pulmonary Division to develop a better understanding of pulmonary diseases or for the development of new treatments. Typical research studies that will be conducted on the stored tissue, fluid, or bacteria from the patient sample involve obtaining bacterial cultures, measurement of inflammatory markers, and examination of the characteristics of the tissue. Other similar tests may be done in the future; however, these tests have not all been determined at this time. It is important to note that no genetic testing will be performed on any samples that are obtained as part of this protocol.

Cystic Fibrosis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Tissue Bank for Pulmonary Diseases

Resource links provided by NLM:

Further study details as provided by Boston Children’s Hospital:

Estimated Enrollment: 400
Study Start Date: April 1999

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Cystic Fibrosis Patients, Pulmonary Patients

Inclusion Criteria:

  • Open
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00546962

United States, Massachusetts
Children's Hospital Recruiting
Boston, Massachusetts, United States, 02115
Contact: Ashish George    617-355-6665    ashish.george@childrens.harvard.edu   
Sponsors and Collaborators
Boston Children’s Hospital
Harvard University
Principal Investigator: Thomas Martin, MD Boston Children’s Hospital
  More Information

Responsible Party: Thomas Martin, MD, Childrens Hospital Boston
ClinicalTrials.gov Identifier: NCT00546962     History of Changes
Other Study ID Numbers: 05-02-014R
First Submitted: October 17, 2007
First Posted: October 19, 2007
Last Update Posted: May 13, 2011
Last Verified: May 2011

Additional relevant MeSH terms:
Lung Diseases
Cystic Fibrosis
Respiratory Tract Diseases
Pancreatic Diseases
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases